United Health Services Hospitals Inc – New Horizons Chemical Dependency Program provides drug and alcohol treatment from its location at 10-42 Mitchell Avenue Binghamton General Hospital in Binghamton, New York. It is a nonprofit provider. The New Horizons Chemical Dependency Program program is operated by United Health Services Hospitals Inc.
Levels of care offered here include intensive outpatient (IOP), standard outpatient counseling, medication-assisted treatment (MAT), co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, community reinforcement plus vouchers, and motivational interviewing. For opioid use disorder, the program uses buprenorphine and naltrexone. It also prescribes medication for alcohol use disorder.
United Health Services Hospitals Inc – New Horizons Chemical Dependency Program accepts government funding for substance use treatment, Medicare, Medicaid, military insurance (TRICARE), private health insurance, cash or self-payment, state-financed health insurance plan other than Medicaid, and SAMHSA funding/block grants. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts children/adolescents, young adults, adults, and seniors. It offers specialized groups for adolescents, pregnant/postpartum women, criminal justice (other than DUI/DWI)/Forensic clients, and clients with co-occurring mental and substance use disorders. Sign language services are available for deaf and hard-of-hearing clients.
United Health Services Hospitals Inc – New Horizons Chemical Dependency Program is accredited by The Joint Commission and licensed or certified by the state substance use treatment agency, state department of health, and drug Enforcement Agency (DEA).
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.